Literature DB >> 86039

Association between hepatobiliary cancer and typhoid carrier state.

J C Welton, J S Marr, S M Friedman.   

Abstract

A case-control study of deceased typhoid carriers registered by the New York City Health Department between 1922 and 1975 was carried out to test for an association between the typhoid-carrier state and death due to hepatobiliary cancer. 471 carriers were matched with 942 controls for sex, age at death, year of death, borough in which the carrier died, and where they were born. The results show that chronic typhoid carriers die of hepatobiliary cancer six times more often than the matched controls and that this difference is significant (P less than 0.001) by simple chi2 test and by the Mantel-Haenszel method of chi2 for matched triples. Possible mechanisms for this association are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86039     DOI: 10.1016/s0140-6736(79)91315-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

Review 1.  Taming the elephant: Salmonella biology, pathogenesis, and prevention.

Authors:  Helene L Andrews-Polymenis; Andreas J Bäumler; Beth A McCormick; Ferric C Fang
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

Review 2.  The inflammatory inception of gallbladder cancer.

Authors:  Jaime A Espinoza; Carolina Bizama; Patricia García; Catterina Ferreccio; Milind Javle; Juan F Miquel; Jill Koshiol; Juan C Roa
Journal:  Biochim Biophys Acta       Date:  2016-03-12

Review 3.  Acalculous disease of the gall bladder.

Authors:  R C Williamson
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

Review 4.  Antibiotics in the treatment of biliary infection.

Authors:  J S Dooley; J M Hamilton-Miller; W Brumfitt; S Sherlock
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

5.  The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

Authors:  Vu Dinh Thiem; Feng-Ying C Lin; Do Gia Canh; Nguyen Hong Son; Dang Duc Anh; Nguyen Duc Mao; Chiayung Chu; Steven W Hunt; John B Robbins; Rachel Schneerson; Shousun C Szu
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

6.  Carcinoma of the gallbladder--is it a sequel of typhoid?

Authors:  V K Shukla; H Singh; M Pandey; S K Upadhyay; G Nath
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

7.  Mucoepidermoid carcinoma of the bile duct.

Authors:  J Koo; J Ho; J Wong; G B Ong
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

Review 8.  The interplay between the microbiome and the adaptive immune response in cancer development.

Authors:  Edda Russo; Antonio Taddei; Maria Novella Ringressi; Federica Ricci; Amedeo Amedei
Journal:  Therap Adv Gastroenterol       Date:  2016-03-15       Impact factor: 4.409

9.  Mutagenic activity in stones from a patient with a congenital choledochal cyst.

Authors:  P Bull; S Guzmán; F Nervi
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 10.  What should I do about my patient's gall stones?

Authors:  A R Dennison; D Azoulay; N Oakley; H Baer; J A Paraskevopoulos; G J Maddern
Journal:  Postgrad Med J       Date:  1995-12       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.